Literature DB >> 11080815

High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells.

E Hanon1, R E Asquith, G P Taylor, Y Tanaka, J N Weber, C R Bangham.   

Abstract

Most human T cell lymphotropic virus type (HTLV)-1-infected individuals mount a strong and persistently activated cytotoxic T lymphocyte (CTL) response to the virus, which implies that there is abundant chronic transcription of HTLV-1 genes. On the other hand, several observations suggest that HTLV-1 might be latent in vivo and therefore not detectable by CTLs. To clarify these discrepancies, we quantified the frequency of provirus-positive peripheral blood mononuclear cells (PBMCs) that were capable of expressing the HTLV-1 Tax protein, which is known to be the immunodominant target antigen recognized by HTLV-1-specific CTLs. The analysis showed that a significant proportion of HTLV-1-infected cells (from 14 to 100%) starts to express the Tax protein within a few hours of culture ex vivo. Phenotypic analysis confirmed that the main cell subpopulation expressing the Tax protein is CD4 positive. Frequent Tax expression in CD4(+) T lymphocytes in vivo might account for the chronic activation of the cytotoxic immune response observed in the majority of HTLV-1-infected patients and might contribute to the pathogenesis of HTLV-1-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080815     DOI: 10.1089/08892220050193191

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  17 in total

1.  Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo.

Authors:  Amine Achachi; Arnaud Florins; Nicolas Gillet; Christophe Debacq; Patrice Urbain; Germain Manfouo Foutsop; Fabian Vandermeers; Agnieszka Jasik; Michal Reichert; Pierre Kerkhofs; Laurence Lagneaux; Arsène Burny; Richard Kettmann; Luc Willems
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

2.  Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.

Authors:  Yosuke Maeda; Hiromi Terasawa; Yuetsu Tanaka; Chisho Mitsuura; Kaori Nakashima; Keisuke Yusa; Shinji Harada
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

3.  An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein.

Authors:  Josefina D Piñón; Sharon M Kelly; Nicholas C Price; Jack U Flanagan; David W Brighty
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein.

Authors:  Kerstin Haller; Yalin Wu; Elisabeth Derow; Iris Schmitt; Kuan-Teh Jeang; Ralph Grassmann
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 5.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

6.  Suppression of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code.

Authors:  Makram Merimi; Pavel Klener; Maud Szynal; Yvette Cleuter; Pierre Kerkhofs; Arsène Burny; Philippe Martiat; Anne Van den Broeke
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

7.  Nonhelical leash and alpha-helical structures determine the potency of a peptide antagonist of human T-cell leukemia virus entry.

Authors:  Antonis Mirsaliotis; Daniel Lamb; David W Brighty
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

8.  In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.

Authors:  Silva Hilburn; Aileen Rowan; Maria-Antonietta Demontis; Aidan MacNamara; Becca Asquith; Charles R M Bangham; Graham P Taylor
Journal:  J Infect Dis       Date:  2011-01-05       Impact factor: 5.226

9.  The HTLV-1 Virological Synapse.

Authors:  Mohamed Nejmeddine; Charles R M Bangham
Journal:  Viruses       Date:  2010-07-07       Impact factor: 5.818

10.  Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy.

Authors:  Britta Moens; Daniele Decanine; Soraya Maria Menezes; Ricardo Khouri; Gilvanéia Silva-Santos; Giovanni Lopez; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Ramon de Almeida Kruschewsky; Bernardo Galvão-Castro; Anne-Mieke Vandamme; Johan Van Weyenbergh
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.